SRZN DUET study launches for dual VEGF/Wnt therapy in DME
A two-part clinical study for a dual VEGF/Wnt molecule in diabetic macular edema will start this year, focusing on safety, efficacy and unique reperfusion endpoints. Initial data is expected in 2027.